首页 > 最新文献

Experimental and molecular pathology最新文献

英文 中文
Platelet-derived growth factor-C contributes to kidney inflammation in experimental hypertension with little effect on the peritubular capillary network 血小板源性生长因子- c参与实验性高血压肾炎症,对小管周围毛细血管网络影响不大
IF 3.7 4区 医学 Q2 PATHOLOGY Pub Date : 2025-08-28 DOI: 10.1016/j.yexmp.2025.104994
Ina V. Martin , Christian Dippel , Eva M. Buhl , Robert Göllinger , Katja Ermert , Jürgen Floege , Eleni Stamellou , Ute Raffetseder , Rafael Kramann , Tammo Ostendorf

Background and aims

Platelet-Derived Growth Factor (PDGF)-C plays a significant role in kidney fibrosis, angiogenesis, and hypertension. While its involvement in the healing of damaged glomerular capillaries is well recognized, its function in kidney peritubular capillaries (PTCs) remains less understood. Therefore, this study investigates the role of PDGF-C in PTCs under both homeostatic conditions and experimentally angiotensin II (AngII)-induced hypertension.

Materials and methods

We utilized mice with systemic PDGF-C antagonism or conditional deletion of endothelial-derived PDGF-C (Cdh5-cre::Pdgfcflox/flox) in an AngII-induced hypertension model. The PTC network, glycocalyx, and inflammatory parameters in the kidneys were analyzed and quantified using qPCR, electron microscopy, and fluorescence microscopy.

Results

Systemic antagonism of PDGF-C in the AngII model reduced peritubular accumulation of PDGF receptor-expressing mesenchymal cells and the expression of Ccl2, Plat and Nos3, while PTC density and glycocalyx-regulating genes remained unaffected. Conditional deletion of endothelial cell-derived PDGF-C did not affect peritubular accumulation of mesenchymal cells, blood pressure or genes associated with angiogenesis; it also had no impact on the PTC network or glycocalyx. Notably, a reduction in inflammatory infiltrates was observed in the hypertensive Cdh5-cre::Pdgfcflox/flox -mice.

Conclusion

Despite influencing certain parameters critical for endothelial homeostasis, such as PDGFR+ pericyte recruitment following systemic PDGF-C antagonism during hypertension, PDGF-C has minimal effects on the PTC network. Conversely, both systemic and endothelial cell-derived PDGF-C modulate the inflammatory response associated with hypertension in the kidney. Our findings help mitigate safety concerns about pharmacological PDGF-C targeting and its impact on peritubular capillaries.
背景和目的血小板衍生生长因子(PDGF)-C在肾纤维化、血管生成和高血压中起重要作用。虽然它参与损伤的肾小球毛细血管的愈合是公认的,但它在肾小管周围毛细血管(ptc)中的功能仍然知之甚少。因此,本研究探讨了PDGF-C在稳态条件下和血管紧张素II (AngII)诱导高血压的ptc中的作用。材料和方法我们在血管诱导的高血压模型中使用了全身PDGF-C拮抗或条件缺失内皮源性PDGF-C (Cdh5-cre:: pdgfflox /flox)的小鼠。采用qPCR、电镜和荧光显微镜对肾脏PTC网络、糖萼和炎症参数进行分析和定量。结果在AngII模型中,PDGF- c的全身拮抗降低了表达PDGF受体的间充质细胞的小管周围积聚以及Ccl2、Plat和Nos3的表达,而PTC密度和糖萼调节基因未受影响。内皮细胞来源的PDGF-C的条件性缺失不影响小管周围间充质细胞的积聚、血压或与血管生成相关的基因;它对PTC网络或糖萼也没有影响。值得注意的是,在高血压Cdh5-cre::Pdgfcflox/flox -小鼠中观察到炎症浸润减少。结论:尽管PDGF-C会影响内皮稳态的某些关键参数,如高血压患者全身PDGF-C拮抗后PDGFR+周细胞募集,但PDGF-C对PTC网络的影响很小。相反,全身和内皮细胞来源的PDGF-C都能调节与肾脏高血压相关的炎症反应。我们的研究结果有助于减轻药物PDGF-C靶向及其对小管周围毛细血管影响的安全性担忧。
{"title":"Platelet-derived growth factor-C contributes to kidney inflammation in experimental hypertension with little effect on the peritubular capillary network","authors":"Ina V. Martin ,&nbsp;Christian Dippel ,&nbsp;Eva M. Buhl ,&nbsp;Robert Göllinger ,&nbsp;Katja Ermert ,&nbsp;Jürgen Floege ,&nbsp;Eleni Stamellou ,&nbsp;Ute Raffetseder ,&nbsp;Rafael Kramann ,&nbsp;Tammo Ostendorf","doi":"10.1016/j.yexmp.2025.104994","DOIUrl":"10.1016/j.yexmp.2025.104994","url":null,"abstract":"<div><h3>Background and aims</h3><div>Platelet-Derived Growth Factor (PDGF)-C plays a significant role in kidney fibrosis, angiogenesis, and hypertension. While its involvement in the healing of damaged glomerular capillaries is well recognized, its function in kidney peritubular capillaries (PTCs) remains less understood. Therefore, this study investigates the role of PDGF-C in PTCs under both homeostatic conditions and experimentally angiotensin II (AngII)-induced hypertension.</div></div><div><h3>Materials and methods</h3><div>We utilized mice with systemic PDGF-C antagonism or conditional deletion of endothelial-derived PDGF-C (<em>Cdh5-cre::Pdgfc</em><sup><em>flox/flox</em></sup>) in an AngII-induced hypertension model. The PTC network, glycocalyx, and inflammatory parameters in the kidneys were analyzed and quantified using qPCR, electron microscopy, and fluorescence microscopy.</div></div><div><h3>Results</h3><div>Systemic antagonism of PDGF-C in the AngII model reduced peritubular accumulation of PDGF receptor-expressing mesenchymal cells and the expression of <em>Ccl2</em>, <em>Plat</em> and <em>Nos3</em>, while PTC density and glycocalyx-regulating genes remained unaffected. Conditional deletion of endothelial cell-derived PDGF-C did not affect peritubular accumulation of mesenchymal cells, blood pressure or genes associated with angiogenesis; it also had no impact on the PTC network or glycocalyx. Notably, a reduction in inflammatory infiltrates was observed in the hypertensive <em>Cdh5-cre::Pdgfc</em><sup><em>flox/flox</em></sup> -mice.</div></div><div><h3>Conclusion</h3><div>Despite influencing certain parameters critical for endothelial homeostasis, such as PDGFR<sup>+</sup> pericyte recruitment following systemic PDGF-C antagonism during hypertension, PDGF-C has minimal effects on the PTC network. Conversely, both systemic and endothelial cell-derived PDGF-C modulate the inflammatory response associated with hypertension in the kidney. Our findings help mitigate safety concerns about pharmacological PDGF-C targeting and its impact on peritubular capillaries.</div></div>","PeriodicalId":12176,"journal":{"name":"Experimental and molecular pathology","volume":"143 ","pages":"Article 104994"},"PeriodicalIF":3.7,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144907621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peroxidasin expression is increased in intratumoural capillaries and in proximal tubular cells adjacent to clear cell renal cell carcinoma. 过氧化物酶表达在瘤内毛细血管和靠近透明细胞肾细胞癌的近端小管细胞中增加。
IF 3.7 4区 医学 Q2 PATHOLOGY Pub Date : 2025-08-19 DOI: 10.1016/j.yexmp.2025.104993
Roberto Silva , Jorge Reis Almeida , Ana Rita Coelho , Isabel Brandão , Bárbara Gomes , Inês Soares Alencastre , João Paulo Oliveira
Peroxidasin (PXDN), is a heme peroxidase with a critical role in the crosslinking of type IV collagen, being essential for basement membrane integrity. Overexpression of PXDN has been associated with poor clinical outcomes in many cancers; however, little is currently known about its role in renal cell carcinoma (RCC). In this study, we characterized the expression of PXDN in tumour tissue and adjacent non-neoplastic tissue from cases of clear cell renal cell carcinoma (ccRCC), chromophobe RCC (chRCC), and renal oncocytoma using immunohistochemistry. Our results revealed increased PXDN expression in the intratumoural capillaries of ccRCC compared to other tumour types, including oncocytoma. Additionally, there was a notable increase in PXDN expression in the proximal tubular epithelial cells of non-neoplastic adjacent parenchyma in ccRCC cases compared to the same region in oncocytomas. These findings suggest, for the first time, that PXDN may play a role in tumour angiogenesis, potentially promoting metastases and malignancy. Furthermore, PXDN may be involved in the crosstalk between the tumour and adjacent tissues, a mechanism warranting further investigation.
过氧化物酶(PXDN)是一种血红素过氧化物酶,在IV型胶原的交联中起关键作用,对基底膜的完整性至关重要。PXDN过表达与许多癌症的不良临床结果相关;然而,目前对其在肾细胞癌(RCC)中的作用知之甚少。在这项研究中,我们用免疫组织化学方法表征了PXDN在透明细胞肾细胞癌(ccRCC)、憎色肾细胞癌(chRCC)和肾癌细胞瘤的肿瘤组织和邻近非肿瘤组织中的表达。我们的研究结果显示,与其他类型的肿瘤(包括嗜瘤细胞瘤)相比,ccRCC的肿瘤内毛细血管中PXDN的表达增加。此外,与癌细胞瘤的相同区域相比,ccRCC病例中非肿瘤性相邻实质近端小管上皮细胞的PXDN表达明显增加。这些发现首次表明,PXDN可能在肿瘤血管生成中发挥作用,可能促进转移和恶性肿瘤。此外,PXDN可能参与肿瘤和邻近组织之间的串扰,这一机制值得进一步研究。
{"title":"Peroxidasin expression is increased in intratumoural capillaries and in proximal tubular cells adjacent to clear cell renal cell carcinoma.","authors":"Roberto Silva ,&nbsp;Jorge Reis Almeida ,&nbsp;Ana Rita Coelho ,&nbsp;Isabel Brandão ,&nbsp;Bárbara Gomes ,&nbsp;Inês Soares Alencastre ,&nbsp;João Paulo Oliveira","doi":"10.1016/j.yexmp.2025.104993","DOIUrl":"10.1016/j.yexmp.2025.104993","url":null,"abstract":"<div><div>Peroxidasin (PXDN), is a heme peroxidase with a critical role in the crosslinking of type IV collagen, being essential for basement membrane integrity. Overexpression of PXDN has been associated with poor clinical outcomes in many cancers; however, little is currently known about its role in renal cell carcinoma (RCC). In this study, we characterized the expression of PXDN in tumour tissue and adjacent non-neoplastic tissue from cases of clear cell renal cell carcinoma (ccRCC), chromophobe RCC (chRCC), and renal oncocytoma using immunohistochemistry. Our results revealed increased PXDN expression in the intratumoural capillaries of ccRCC compared to other tumour types, including oncocytoma. Additionally, there was a notable increase in PXDN expression in the proximal tubular epithelial cells of non-neoplastic adjacent parenchyma in ccRCC cases compared to the same region in oncocytomas. These findings suggest, for the first time, that PXDN may play a role in tumour angiogenesis, potentially promoting metastases and malignancy. Furthermore, PXDN may be involved in the crosstalk between the tumour and adjacent tissues, a mechanism warranting further investigation.</div></div>","PeriodicalId":12176,"journal":{"name":"Experimental and molecular pathology","volume":"143 ","pages":"Article 104993"},"PeriodicalIF":3.7,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144866366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research progress of sarcopenia: Diagnostic advancements, molecular mechanisms, and therapeutic strategies 肌少症的研究进展:诊断进展、分子机制和治疗策略
IF 3.7 4区 医学 Q2 PATHOLOGY Pub Date : 2025-08-14 DOI: 10.1016/j.yexmp.2025.104992
Hao-lin Wang , Long-long Liu , Ze-yu Tan , Yuan Zhou , Jing Zhang , Lin Zhai , Qian Xie , Rong-hua Liu
Muscle atrophy or loss is an important sign of human aging. As the aging society approaches and human lifespan prolongs, sarcopenia has emerged as one of the significant risks influencing the quality of life of the elderly. Sarcopenia is a progressive geriatric syndrome characterized by the deterioration of skeletal muscle mass and function, which can result in an increased risk of falls, fractures, restricted physical activity, disability, mortality, and a remarkable escalation in the risk of cardiovascular diseases among the elderly. This work synthesizes recent advances in sarcopenia research, critically evaluating diagnostic frameworks, histopathological hallmarks, and molecular pathways driving disease progression. Additionally, we provide an in-depth analysis of evidence-based exercise and nutritional interventions, identifying key research gaps. These insights offer valuable references for future research on sarcopenia and clinical management, as well as lifestyle interventions such as exercise and nutrition.
肌肉萎缩或丧失是人类衰老的重要标志。随着老龄化社会的临近和人类寿命的延长,肌肉减少症已成为影响老年人生活质量的重要风险之一。骨骼肌减少症是一种以骨骼肌质量和功能退化为特征的进行性老年综合征,可导致老年人跌倒、骨折、体力活动受限、残疾、死亡的风险增加,并显著增加心血管疾病的风险。这项工作综合了肌少症研究的最新进展,批判性地评估了诊断框架、组织病理学特征和驱动疾病进展的分子途径。此外,我们还对基于证据的运动和营养干预进行了深入分析,确定了关键的研究空白。这些见解为未来肌肉减少症的研究和临床管理,以及运动和营养等生活方式干预提供了有价值的参考。
{"title":"Research progress of sarcopenia: Diagnostic advancements, molecular mechanisms, and therapeutic strategies","authors":"Hao-lin Wang ,&nbsp;Long-long Liu ,&nbsp;Ze-yu Tan ,&nbsp;Yuan Zhou ,&nbsp;Jing Zhang ,&nbsp;Lin Zhai ,&nbsp;Qian Xie ,&nbsp;Rong-hua Liu","doi":"10.1016/j.yexmp.2025.104992","DOIUrl":"10.1016/j.yexmp.2025.104992","url":null,"abstract":"<div><div>Muscle atrophy or loss is an important sign of human aging. As the aging society approaches and human lifespan prolongs, sarcopenia has emerged as one of the significant risks influencing the quality of life of the elderly. Sarcopenia is a progressive geriatric syndrome characterized by the deterioration of skeletal muscle mass and function, which can result in an increased risk of falls, fractures, restricted physical activity, disability, mortality, and a remarkable escalation in the risk of cardiovascular diseases among the elderly. This work synthesizes recent advances in sarcopenia research, critically evaluating diagnostic frameworks, histopathological hallmarks, and molecular pathways driving disease progression. Additionally, we provide an in-depth analysis of evidence-based exercise and nutritional interventions, identifying key research gaps. These insights offer valuable references for future research on sarcopenia and clinical management, as well as lifestyle interventions such as exercise and nutrition.</div></div>","PeriodicalId":12176,"journal":{"name":"Experimental and molecular pathology","volume":"143 ","pages":"Article 104992"},"PeriodicalIF":3.7,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144829736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The interplay involving oxidative stress and autophagy: Mechanisms, implications, and therapeutic opportunities 氧化应激和自噬的相互作用:机制、意义和治疗机会
IF 3.7 4区 医学 Q2 PATHOLOGY Pub Date : 2025-08-01 DOI: 10.1016/j.yexmp.2025.104989
Noha A. Gouda , Assem Zhakupova , Ahmed M. Abdelaal , Firdos Ahmad , Ahmed Elkamhawy
Reactive oxygen species (ROS) are extremely reactive molecules produced during cellular metabolism, which play important roles in signaling and immune responses. Excessive ROS accumulation results in oxidative stress and cellular damage. As a result, autophagy (a cellular recycling process) is induced to overcome oxidative stress conditions by eliminating impaired cellular components. By selectively targeting and degrading dysfunctional mitochondria and peroxisomes through mitophagy and pexophagy, respectively, cells can effectively reduce ROS accumulation. Conversely, oxidative stress can disrupt autophagy, impairing protein aggregate clearance and thereby exacerbating ROS accumulation. In this review, we discuss the complex correlation between oxidative stress and autophagy, highlighting the mechanisms of regulation and their pathological implications. Additionally, we discuss the latest advances and challenges in developing autophagy-modulating therapies.
活性氧(Reactive oxygen species, ROS)是细胞代谢过程中产生的极具活性的分子,在信号传导和免疫应答中发挥重要作用。过多的ROS积累导致氧化应激和细胞损伤。因此,诱导自噬(细胞循环过程)通过消除受损的细胞成分来克服氧化应激条件。细胞分别通过线粒体自噬和过氧化物酶体自噬选择性靶向和降解功能失调的线粒体和过氧化物酶体,可以有效地减少ROS的积累。相反,氧化应激可破坏自噬,损害蛋白质聚集清除,从而加剧ROS积累。在这篇综述中,我们讨论了氧化应激和自噬之间的复杂关系,重点介绍了调节机制及其病理意义。此外,我们还讨论了自噬调节疗法的最新进展和挑战。
{"title":"The interplay involving oxidative stress and autophagy: Mechanisms, implications, and therapeutic opportunities","authors":"Noha A. Gouda ,&nbsp;Assem Zhakupova ,&nbsp;Ahmed M. Abdelaal ,&nbsp;Firdos Ahmad ,&nbsp;Ahmed Elkamhawy","doi":"10.1016/j.yexmp.2025.104989","DOIUrl":"10.1016/j.yexmp.2025.104989","url":null,"abstract":"<div><div>Reactive oxygen species (ROS) are extremely reactive molecules produced during cellular metabolism, which play important roles in signaling and immune responses. Excessive ROS accumulation results in oxidative stress and cellular damage. As a result, autophagy (a cellular recycling process) is induced to overcome oxidative stress conditions by eliminating impaired cellular components. By selectively targeting and degrading dysfunctional mitochondria and peroxisomes through mitophagy and pexophagy, respectively, cells can effectively reduce ROS accumulation. Conversely, oxidative stress can disrupt autophagy, impairing protein aggregate clearance and thereby exacerbating ROS accumulation. In this review, we discuss the complex correlation between oxidative stress and autophagy, highlighting the mechanisms of regulation and their pathological implications. Additionally, we discuss the latest advances and challenges in developing autophagy-modulating therapies.</div></div>","PeriodicalId":12176,"journal":{"name":"Experimental and molecular pathology","volume":"143 ","pages":"Article 104989"},"PeriodicalIF":3.7,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144757616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Twenty-eight-day perfluorooctanoate exposure does not affect immune cell populations in naïve mice 接触全氟辛酸28天不会影响naïve小鼠的免疫细胞群
IF 3.7 4区 医学 Q2 PATHOLOGY Pub Date : 2025-07-30 DOI: 10.1016/j.yexmp.2025.104990
Candice Limper , Crystal Silliman , Ethan Cho , Amanda Ng , Steven Yang , Zachary Hammer , Isabella Ciocca , Brian Imbiakha , Amie Redko , Colleen M. Lau , Sue Chang , Julie Sahler , Avery August
Perfluorooctanoate (C7F15CO2, PFOA) is a perfluorinated compound widely used in the production of industrial products, such as non-stick cookware and firefighting foams. Although its production has been phased out in the United States, PFOA remains prevalent in the environment due to its persistence and resistance to degradation. As a result, trace levels of PFOA is detectable in water, soil, biota, and the general population. Environmental and toxicological concerns have emerged due to potential health risks associated with PFOA exposure, including effects on the immune system. Basic underlying knowledge gaps exist for potential effects of PFOA on baseline immune cell maintenance in the absence of overt liver hypertrophy. In this study, we assessed the immune-related effects of 28-day daily PFOA exposure in adult naïve mice, using doses of 20 ng/kg/day, 200 ng/kg/day, 2 μg/kg/day, and 40 μg/kg/day, resulting in mean serum PFOA concentrations of non-detectable, 6.979 ng/mL, 80.03 ng/mL, and 1773 ng/mL respectively, representative of levels seen in the general human population (∼1.5 ng/mL), community-exposed residents (∼225 ng/mL), and occupational workers (∼2000 ng/mL). Evaluation of immune cell populations in bone marrow, thymus, spleen, liver, and lymph nodes, along with serum antibodies indicate that 28 days of PFOA exposure had no effect on proportion and number of immune cell populations nor serum antibodies, except for a slight decrease in serum IgE at the highest dose. By contrast, mice receiving CTX, a known immune suppressant, exhibited a wide array of biological responses, which were absent from PFOA-treated mice. These findings contribute to understanding the potential immune effects of environmentally relevant PFOA exposure.
全氟辛酸盐(C7F15CO2−,PFOA)是一种全氟化合物,广泛用于工业产品的生产,如不粘锅和消防泡沫。尽管PFOA的生产在美国已被逐步淘汰,但由于其持久性和抗降解性,PFOA在环境中仍然普遍存在。因此,在水、土壤、生物群和一般人群中都可以检测到痕量的全氟辛酸。由于接触全氟辛酸可能带来健康风险,包括对免疫系统的影响,环境和毒理学问题已经出现。在没有明显肝肥大的情况下,PFOA对基线免疫细胞维持的潜在影响存在基本的潜在知识空白。在这项研究中,我们评估了成年naïve小鼠每天暴露28天的PFOA的免疫相关影响,剂量分别为20 ng/kg/day, 200 ng/kg/day, 2 μg/kg/day和40 μg/kg/day,结果血清PFOA平均浓度分别为6.979 ng/mL, 80.03 ng/mL和1773 ng/mL,代表了一般人群(~ 1.5 ng/mL),社区暴露居民(~ 225 ng/mL)和职业工人(~ 2000 ng/mL)的水平。对骨髓、胸腺、脾脏、肝脏和淋巴结的免疫细胞群以及血清抗体的评估表明,接触PFOA 28天对免疫细胞群的比例和数量以及血清抗体没有影响,除了在最高剂量时血清IgE略有下降。相比之下,接受CTX(一种已知的免疫抑制剂)的小鼠表现出广泛的生物反应,这在pfoa治疗的小鼠中是不存在的。这些发现有助于了解与环境相关的全氟辛酸暴露的潜在免疫效应。
{"title":"Twenty-eight-day perfluorooctanoate exposure does not affect immune cell populations in naïve mice","authors":"Candice Limper ,&nbsp;Crystal Silliman ,&nbsp;Ethan Cho ,&nbsp;Amanda Ng ,&nbsp;Steven Yang ,&nbsp;Zachary Hammer ,&nbsp;Isabella Ciocca ,&nbsp;Brian Imbiakha ,&nbsp;Amie Redko ,&nbsp;Colleen M. Lau ,&nbsp;Sue Chang ,&nbsp;Julie Sahler ,&nbsp;Avery August","doi":"10.1016/j.yexmp.2025.104990","DOIUrl":"10.1016/j.yexmp.2025.104990","url":null,"abstract":"<div><div>Perfluorooctanoate (C<sub>7</sub>F<sub>15</sub>CO<sub>2</sub><sup>−</sup>, PFOA) is a perfluorinated compound widely used in the production of industrial products, such as non-stick cookware and firefighting foams. Although its production has been phased out in the United States, PFOA remains prevalent in the environment due to its persistence and resistance to degradation. As a result, trace levels of PFOA is detectable in water, soil, biota, and the general population. Environmental and toxicological concerns have emerged due to potential health risks associated with PFOA exposure, including effects on the immune system. Basic underlying knowledge gaps exist for potential effects of PFOA on baseline immune cell maintenance in the absence of overt liver hypertrophy. In this study, we assessed the immune-related effects of 28-day daily PFOA exposure in adult naïve mice, using doses of 20 ng/kg/day, 200 ng/kg/day, 2 μg/kg/day, and 40 μg/kg/day, resulting in mean serum PFOA concentrations of non-detectable, 6.979 ng/mL, 80.03 ng/mL, and 1773 ng/mL respectively, representative of levels seen in the general human population (∼1.5 ng/mL), community-exposed residents (∼225 ng/mL), and occupational workers (∼2000 ng/mL). Evaluation of immune cell populations in bone marrow, thymus, spleen, liver, and lymph nodes, along with serum antibodies indicate that 28 days of PFOA exposure had no effect on proportion and number of immune cell populations nor serum antibodies, except for a slight decrease in serum IgE at the highest dose. By contrast, mice receiving CTX, a known immune suppressant, exhibited a wide array of biological responses, which were absent from PFOA-treated mice. These findings contribute to understanding the potential immune effects of environmentally relevant PFOA exposure.</div></div>","PeriodicalId":12176,"journal":{"name":"Experimental and molecular pathology","volume":"143 ","pages":"Article 104990"},"PeriodicalIF":3.7,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144723708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NVP-BEZ235 enhances autophagy and ameliorates cognitive deficits by targeting tauopathies NVP-BEZ235通过靶向tau病变增强自噬并改善认知缺陷
IF 2.8 4区 医学 Q2 PATHOLOGY Pub Date : 2025-07-24 DOI: 10.1016/j.yexmp.2025.104988
Ifat Alsharif
Tauopathies are a class of neurodegenerative disorders characterized by the abnormal accumulation of hyperphosphorylated tau (p-tau) and the formation of neurofibrillary tangles. Autophagy, a fundamental cellular degradation pathway, plays a pivotal role in maintaining proteostasis by facilitating the clearance of misfolded and aggregated proteins. In tauopathies, however, autophagic processes are often impaired, contributing to the pathological buildup of p-tau. NVP-BEZ235, a dual inhibitor of the mammalian target of rapamycin (mTOR) and PI3K, has previously been evaluated in phase I clinical trials for solid tumors and lymphomas. In this study, we investigated the therapeutic potential of NVP-BEZ235 in tauopathy models, both in vitro and in vivo. In SH-SY5Y cells stably expressing human P301L-mutant tau (SH-Tau), NVP-BEZ235 treatment induced a time-dependent increase in LC3B-II and a decrease in p62 levels, consistent with enhanced autophagic activity. Autophagic flux analysis further confirmed the promotion of autophagy upon mTOR pathway inhibition. NVP-BEZ235 significantly reduced tau phosphorylation at multiple residues, including Ser262, Ser396, Ser404, and Thr231, without eliciting cytotoxic effects. In a transgenic mouse model of tauopathy (P301S), chronic treatment with NVP-BEZ235 (20 mg/kg/day for two months) resulted in a marked reduction of both RIPA-soluble and -insoluble p-tau species in the brain. Spatial learning and memory, assessed through Morris water maze and novel object recognition tests, were significantly improved in treated mice. Furthermore, NVP-BEZ235 administration reduced neuroinflammatory markers and pro-inflammatory cytokine levels (TNF-α, IL-1β, IL-6), while also enhancing autophagic markers in brain tissue. Hematological analysis and organ histology revealed no signs of systemic toxicity. Collectively, these findings demonstrate that NVP-BEZ235 facilitates tau clearance by enhancing autophagy through mTOR inhibition, thereby mitigating cognitive deficits and neuroinflammation in tauopathy models. This study supports the therapeutic potential of NVP-BEZ235 as a promising candidate for the treatment of tau-related neurodegenerative diseases.
tau病是一类神经退行性疾病,其特征是过度磷酸化tau蛋白(p-tau)的异常积累和神经原纤维缠结的形成。自噬是一种基本的细胞降解途径,通过促进错误折叠和聚集蛋白的清除,在维持蛋白质稳态中起着关键作用。然而,在tau病变中,自噬过程经常受损,导致p-tau的病理积累。NVP-BEZ235是哺乳动物雷帕霉素靶点(mTOR)和PI3K的双重抑制剂,此前已在实体瘤和淋巴瘤的I期临床试验中进行了评估。在这项研究中,我们在体外和体内研究了NVP-BEZ235在牛头病模型中的治疗潜力。在稳定表达人类p301l突变型tau (SH-Tau)的SH-SY5Y细胞中,NVP-BEZ235处理诱导LC3B-II的时间依赖性增加和p62水平的降低,与增强的自噬活性一致。自噬通量分析进一步证实mTOR通路抑制对自噬的促进作用。NVP-BEZ235显著降低tau蛋白多个残基的磷酸化,包括Ser262、Ser396、Ser404和Thr231,而不引起细胞毒性作用。在转基因小鼠tau病模型(P301S)中,长期使用NVP-BEZ235 (20 mg/kg/天,持续两个月)导致大脑中ripa可溶性和-不溶性p-tau物质的显著减少。通过Morris水迷宫和新物体识别测试评估,实验组小鼠的空间学习和记忆显著改善。此外,NVP-BEZ235降低了神经炎症标志物和促炎细胞因子(TNF-α, IL-1β, IL-6)水平,同时也增强了脑组织中的自噬标志物。血液学分析和器官组织学未发现系统性毒性的迹象。总的来说,这些发现表明NVP-BEZ235通过抑制mTOR增强自噬,从而促进tau清除,从而减轻tau病模型中的认知缺陷和神经炎症。该研究支持NVP-BEZ235作为治疗tau相关神经退行性疾病的有希望的候选药物的治疗潜力。
{"title":"NVP-BEZ235 enhances autophagy and ameliorates cognitive deficits by targeting tauopathies","authors":"Ifat Alsharif","doi":"10.1016/j.yexmp.2025.104988","DOIUrl":"10.1016/j.yexmp.2025.104988","url":null,"abstract":"<div><div>Tauopathies are a class of neurodegenerative disorders characterized by the abnormal accumulation of hyperphosphorylated tau (p-tau) and the formation of neurofibrillary tangles. Autophagy, a fundamental cellular degradation pathway, plays a pivotal role in maintaining proteostasis by facilitating the clearance of misfolded and aggregated proteins. In tauopathies, however, autophagic processes are often impaired, contributing to the pathological buildup of p-tau. NVP-BEZ235, a dual inhibitor of the mammalian target of rapamycin (mTOR) and PI3K, has previously been evaluated in phase I clinical trials for solid tumors and lymphomas. In this study, we investigated the therapeutic potential of NVP-BEZ235 in tauopathy models, both in vitro and in vivo. In SH-SY5Y cells stably expressing human P301L-mutant tau (SH-Tau), NVP-BEZ235 treatment induced a time-dependent increase in LC3B-II and a decrease in p62 levels, consistent with enhanced autophagic activity. Autophagic flux analysis further confirmed the promotion of autophagy upon mTOR pathway inhibition. NVP-BEZ235 significantly reduced tau phosphorylation at multiple residues, including Ser262, Ser396, Ser404, and Thr231, without eliciting cytotoxic effects. In a transgenic mouse model of tauopathy (P301S), chronic treatment with NVP-BEZ235 (20 mg/kg/day for two months) resulted in a marked reduction of both RIPA-soluble and -insoluble p-tau species in the brain. Spatial learning and memory, assessed through Morris water maze and novel object recognition tests, were significantly improved in treated mice. Furthermore, NVP-BEZ235 administration reduced neuroinflammatory markers and pro-inflammatory cytokine levels (TNF-α, IL-1β, IL-6), while also enhancing autophagic markers in brain tissue. Hematological analysis and organ histology revealed no signs of systemic toxicity. Collectively, these findings demonstrate that NVP-BEZ235 facilitates tau clearance by enhancing autophagy through mTOR inhibition, thereby mitigating cognitive deficits and neuroinflammation in tauopathy models. This study supports the therapeutic potential of NVP-BEZ235 as a promising candidate for the treatment of tau-related neurodegenerative diseases.</div></div>","PeriodicalId":12176,"journal":{"name":"Experimental and molecular pathology","volume":"143 ","pages":"Article 104988"},"PeriodicalIF":2.8,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144696821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Daidzin suppresses melanogenesis through ERK and AKT signaling pathways mediated MITF proteasomal degradation 大豆苷通过ERK和AKT信号通路介导MITF蛋白酶体降解抑制黑素形成
IF 2.8 4区 医学 Q2 PATHOLOGY Pub Date : 2025-07-21 DOI: 10.1016/j.yexmp.2025.104986
Jinpeng Lv , Kun Zou , Chuanwei Yin , Wenhui Xu , Duo Meng , Huansha Zhang , Wenhao Yu , Peiwen Jiang , Changjun Yun , Hui Xue , Nan Hu , Rongyin Gao
Daidzin, a prominent isoflavone found in soybeans, Pueraria lobata, and various legumes, has been extensively investigated for its diverse pharmacological activities, which include anticancer, antioxidant, anti-inflammatory, antiepileptic, and alcohol detoxification properties. Previous studies have shown that the dichloromethane fraction of Pueraria lobata stem (DCM-PLS) exhibits significant anti-melanogenic activity, with daidzin identified as the principal active compound. However, the precise role of daidzin in pigmentation remains incompletely understood. This study aimed to investigate the effects of daidzin on pigmentation and to elucidate the underlying mechanisms. Our findings revealed that daidzin not only inhibited basal melanin production but also reduced melanin synthesis induced by α-MSH, ACTH, and UV exposure. The effects of daidzin were primarily mediated through the activation of the extracellular signal-regulated protein kinase (ERK) and protein kinase B (AKT) pathways. Upon activation, these pathways facilitated the ubiquitination and degradation of Melanocytes Inducing Transcription Factor (MITF), resulting in decreased expression of tyrosinase, TRP-1, and TRP-2, ultimately inhibiting melanogenesis. Importantly, our research further demonstrated that daidzin reduced pigmentation in both zebrafish and human skin explants, highlighting its potential application as a therapeutic approach for disorders related to skin pigmentation.
大豆黄酮是一种在大豆、葛根和各种豆类中发现的重要异黄酮,因其多种药理活性而被广泛研究,包括抗癌、抗氧化、抗炎、抗癫痫和酒精解毒特性。已有研究表明,葛根二氯甲烷组分(DCM-PLS)具有显著的抗黑素活性,其中大豆苷元被鉴定为主要活性化合物。然而,大豆苷元在色素沉着中的确切作用仍不完全清楚。本研究旨在探讨大豆苷元对色素沉着的影响,并探讨其作用机制。研究结果表明,大豆苷元不仅能抑制基础黑色素的生成,还能降低α-MSH、ACTH和紫外线照射诱导的黑色素合成。大豆苷元的作用主要通过激活细胞外信号调节蛋白激酶(ERK)和蛋白激酶B (AKT)途径介导。激活后,这些通路促进了黑色素细胞诱导转录因子(melanocyte Inducing Transcription Factor, MITF)的泛素化和降解,导致酪氨酸酶、TRP-1和TRP-2的表达降低,最终抑制黑色素生成。重要的是,我们的研究进一步证明了大豆苷元减少斑马鱼和人类皮肤外植体的色素沉着,突出了其作为治疗皮肤色素沉着相关疾病的潜在应用。
{"title":"Daidzin suppresses melanogenesis through ERK and AKT signaling pathways mediated MITF proteasomal degradation","authors":"Jinpeng Lv ,&nbsp;Kun Zou ,&nbsp;Chuanwei Yin ,&nbsp;Wenhui Xu ,&nbsp;Duo Meng ,&nbsp;Huansha Zhang ,&nbsp;Wenhao Yu ,&nbsp;Peiwen Jiang ,&nbsp;Changjun Yun ,&nbsp;Hui Xue ,&nbsp;Nan Hu ,&nbsp;Rongyin Gao","doi":"10.1016/j.yexmp.2025.104986","DOIUrl":"10.1016/j.yexmp.2025.104986","url":null,"abstract":"<div><div>Daidzin, a prominent isoflavone found in soybeans, <em>Pueraria lobata</em>, and various legumes, has been extensively investigated for its diverse pharmacological activities, which include anticancer, antioxidant, anti-inflammatory, antiepileptic, and alcohol detoxification properties. Previous studies have shown that the dichloromethane fraction of <em>Pueraria lobata</em> stem (DCM-PLS) exhibits significant anti-melanogenic activity, with daidzin identified as the principal active compound. However, the precise role of daidzin in pigmentation remains incompletely understood. This study aimed to investigate the effects of daidzin on pigmentation and to elucidate the underlying mechanisms. Our findings revealed that daidzin not only inhibited basal melanin production but also reduced melanin synthesis induced by α-MSH, ACTH, and UV exposure. The effects of daidzin were primarily mediated through the activation of the extracellular signal-regulated protein kinase (ERK) and protein kinase B (AKT) pathways. Upon activation, these pathways facilitated the ubiquitination and degradation of Melanocytes Inducing Transcription Factor (MITF), resulting in decreased expression of tyrosinase, TRP-1, and TRP-2, ultimately inhibiting melanogenesis. Importantly, our research further demonstrated that daidzin reduced pigmentation in both zebrafish and human skin explants, highlighting its potential application as a therapeutic approach for disorders related to skin pigmentation.</div></div>","PeriodicalId":12176,"journal":{"name":"Experimental and molecular pathology","volume":"143 ","pages":"Article 104986"},"PeriodicalIF":2.8,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144680738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modulating cellular deformability via 3D dextran hydrogel cultivation to regulate the microcirculation of mesenchymal stem cells in murine spleen and liver 三维右旋糖酐水凝胶培养对小鼠脾、肝间充质干细胞微循环的调节作用
IF 2.8 4区 医学 Q2 PATHOLOGY Pub Date : 2025-07-19 DOI: 10.1016/j.yexmp.2025.104987
Xiaolu Zhu , Zheng Wang , Yuanping Shi , Shuang Yao , Fengliang He , Xiuli Cong , Fang Teng
For mesenchymal stem cell (MSC) therapy to be effective, the vascular system may be used to deliver and steer the cells to the target tissue. However, the expanded MSCs in petri dishes typically exhibit limited deformability and commonly excluded by the capillary networks when homing to the downstream organs via microcirculation. Here, we propose to utilize specially designed 3D dextran hydrogels and tuning the microscopic heterogeneity of hydrogel composition to make the administrated cells mechanically comply with the structure and mechanics of the capillary. The deformability of cells cultured in petri dishes, microcosmically homogeneous (HOM), and heterogeneous (HET) dextran hydrogels was investigated in vitro by measuring cell moduli through atomic force microscope (AFM), analyzing the expression of cytoskeletal protein via flow cytometry and fluorescent imaging. The in vitro experimental results demonstrate a progressive increase in cell deformability from 2D dishes, to HOM-hydrogel derived cells, and then to HET-hydrogel derived cells. The in vivo mouse experiment indicates the cells could deform accordingly and pass through easily with reduced resistance inside the mouse organs. It is suggested that the main destination of hMSC microcirculation could be selected between the spleen and liver of mice, by tuning cell mechanics that depends on the stimulus from HOM or HET hydrogel, which lays a potential foundation for the mechanically modified MSC therapy targeting organ lesions.
为了使间充质干细胞(MSC)治疗有效,血管系统可以用来输送和引导细胞到达目标组织。然而,在培养皿中扩增的MSCs通常表现出有限的可变形性,并且在通过微循环归巢到下游器官时通常被毛细血管网络排除在外。在此,我们提出利用专门设计的三维葡聚糖水凝胶,并调整水凝胶组成的微观异质性,使给药细胞在机械上符合毛细血管的结构和力学。通过原子力显微镜(AFM)测定细胞模量,流式细胞术和荧光成像分析细胞骨架蛋白的表达,研究了培养皿、微观均质(HOM)和非均质(HET)葡聚糖水凝胶培养细胞的体外变形能力。体外实验结果表明,从2D培养皿到homo -水凝胶衍生细胞,再到het -水凝胶衍生细胞,细胞的变形能力逐渐增加。小鼠体内实验表明,细胞在小鼠器官内容易变形并通过,阻力减小。提示可以通过调节依赖于HOM或HET水凝胶刺激的细胞力学,在小鼠的脾脏和肝脏之间选择hMSC微循环的主要目的地,这为靶向器官病变的机械修饰MSC治疗奠定了潜在的基础。
{"title":"Modulating cellular deformability via 3D dextran hydrogel cultivation to regulate the microcirculation of mesenchymal stem cells in murine spleen and liver","authors":"Xiaolu Zhu ,&nbsp;Zheng Wang ,&nbsp;Yuanping Shi ,&nbsp;Shuang Yao ,&nbsp;Fengliang He ,&nbsp;Xiuli Cong ,&nbsp;Fang Teng","doi":"10.1016/j.yexmp.2025.104987","DOIUrl":"10.1016/j.yexmp.2025.104987","url":null,"abstract":"<div><div>For mesenchymal stem cell (MSC) therapy to be effective, the vascular system may be used to deliver and steer the cells to the target tissue. However, the expanded MSCs in petri dishes typically exhibit limited deformability and commonly excluded by the capillary networks when homing to the downstream organs via microcirculation. Here, we propose to utilize specially designed 3D dextran hydrogels and tuning the microscopic heterogeneity of hydrogel composition to make the administrated cells mechanically comply with the structure and mechanics of the capillary. The deformability of cells cultured in petri dishes, microcosmically homogeneous (HOM), and heterogeneous (HET) dextran hydrogels was investigated in vitro by measuring cell moduli through atomic force microscope (AFM), analyzing the expression of cytoskeletal protein via flow cytometry and fluorescent imaging. The in vitro experimental results demonstrate a progressive increase in cell deformability from 2D dishes, to HOM-hydrogel derived cells, and then to HET-hydrogel derived cells. The in vivo mouse experiment indicates the cells could deform accordingly and pass through easily with reduced resistance inside the mouse organs. It is suggested that the main destination of hMSC microcirculation could be selected between the spleen and liver of mice, by tuning cell mechanics that depends on the stimulus from HOM or HET hydrogel, which lays a potential foundation for the mechanically modified MSC therapy targeting organ lesions.</div></div>","PeriodicalId":12176,"journal":{"name":"Experimental and molecular pathology","volume":"143 ","pages":"Article 104987"},"PeriodicalIF":2.8,"publicationDate":"2025-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144662203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment with YKL-05-099, a salt inducible kinase (SIK) inhibitor, attenuates salt-sensitive hypertension: The molecular outcomes of SIK in the kidney 盐诱导激酶(SIK)抑制剂YKL-05-099治疗可减轻盐敏感性高血压:SIK在肾脏中的分子结局
IF 2.8 4区 医学 Q2 PATHOLOGY Pub Date : 2025-07-16 DOI: 10.1016/j.yexmp.2025.104977
Dayene S. Gomes , Bruna Visniauskas , Prasad V.G. Katakam , Rosilane Taveira-da-Silva , Jennifer Lowe , Zoe Vallotton , Minolfa C. Prieto , Lucienne S. Lara
Salt-inducible kinase (SIK) is a serine/threonine kinase that acts as an intracellular Na+ sensor, playing a role in salt-sensitive hypertension. We aimed to evaluate the therapeutic potential of YKL-05-099, a selective SIK inhibitor, in protecting kidney function and attenuating salt-sensitive hypertension. Male adult C57BL/6 J mice were randomly assigned to either a normal sodium (0.5 % NaCl; NS) or high‑sodium diet (4 % NaCl; HS) and further divided into two subgroups – receiving either intraperitoneal injection of saline or SIK inhibitor (SIKi; YKL-05-099, 20 mg/Kg/day). Blood pressure was measured by radiotelemetry for 15 days. On days 7 and 14, mice were placed in metabolic cages for 24 h urine collection. At the end of the treatment, blood and kidneys were collected for renal function assessment, and the renal cortex was extracted for biochemical analysis. HS intake led to a salt-sensitive hypertension model, as seen by increased systolic blood pressure (SPB), kidney damage and impairment in renal function. In the HS, SIKi treatment blocked the elevated SIK activity in the renal cortex, preventing kidney damage, proteinuria, and increased SBP. The Na+ balance was positive due, partly, to a higher (Na++K+)-ATPase activity in the HS. SIKi treatment exerted an anti-inflammatory effect by attenuating HS-dependent macrophage infiltration and ROS production and decreasing the metalloprotease activity. Consequently, the kidney damage biomarker monocyte chemotactic protein type 1 excretion was enhanced. In conclusion, SIK inhibition rescued HS mice from salt-sensitive hypertension and kidney insufficiency by blocking inflammation, metalloprotease activity, and oxidative stress.

Significance

Salt-sensitive hypertension is a major contributor to chronic kidney disease and cardiovascular morbidity worldwide. Despite its prevalence, the underlying mechanisms linking high salt intake to renal injury remain incompletely understood, and targeted therapies are lacking. This study identifies salt-inducible kinase (SIK) as a key mediator of salt-induced renal dysfunction and systemic hypertension. By using a selective SIK inhibitor (YKL-05-099), we demonstrate that pharmacological inhibition of SIK effectively prevents kidney damage, inflammation, oxidative stress, and high blood pressure in a preclinical model of salt-sensitive hypertension. These findings highlight SIK as a promising therapeutic target for preserving renal function and managing salt-induced hypertension, paving the way for novel interventions in salt-related cardiovascular and renal diseases.
盐诱导激酶(SIK)是一种丝氨酸/苏氨酸激酶,作为细胞内Na+传感器,在盐敏感性高血压中发挥作用。我们旨在评估选择性SIK抑制剂YKL-05-099在保护肾功能和减轻盐敏感性高血压方面的治疗潜力。雄性成年C57BL/ 6j小鼠被随机分配到正常钠(0.5% NaCl;NS)或高钠饮食(4% NaCl;HS),并进一步分为两个亚组-接受腹腔注射生理盐水或SIK抑制剂(SIKi;YKL-05-099, 20 mg/Kg/天)。用无线电遥测法测量血压15天。在第7天和第14天,将小鼠置于代谢笼中收集24 h尿液。治疗结束时,取血、取肾评估肾功能,提取肾皮质进行生化分析。HS摄入导致盐敏感型高血压模型,收缩压(SPB)升高,肾损害和肾功能损害。在HS中,SIKi治疗阻断了肾皮质SIK活性升高,防止肾脏损伤、蛋白尿和收缩压升高。Na+平衡是正的,部分原因是HS中较高的(Na++K+)- atp酶活性。SIKi治疗通过降低hs依赖性巨噬细胞浸润和ROS产生,降低金属蛋白酶活性发挥抗炎作用。因此,肾脏损伤生物标志物单核细胞趋化蛋白1型排泄增加。综上所述,SIK抑制可通过抑制炎症、金属蛋白酶活性和氧化应激,使HS小鼠免于盐敏感性高血压和肾功能不全。在世界范围内,盐敏感性高血压是慢性肾脏疾病和心血管疾病的主要致病因素。尽管它很普遍,但高盐摄入与肾损伤之间的潜在机制仍然不完全清楚,而且缺乏靶向治疗。本研究确定盐诱导激酶(SIK)是盐诱导肾功能障碍和全身性高血压的关键介质。通过使用选择性SIK抑制剂(YKL-05-099),我们在盐敏感性高血压的临床前模型中证明了SIK的药理抑制能有效预防肾损害、炎症、氧化应激和高血压。这些发现强调了SIK作为一个有希望的治疗靶点,可以保护肾功能和控制盐性高血压,为盐相关心血管和肾脏疾病的新干预铺平了道路。
{"title":"Treatment with YKL-05-099, a salt inducible kinase (SIK) inhibitor, attenuates salt-sensitive hypertension: The molecular outcomes of SIK in the kidney","authors":"Dayene S. Gomes ,&nbsp;Bruna Visniauskas ,&nbsp;Prasad V.G. Katakam ,&nbsp;Rosilane Taveira-da-Silva ,&nbsp;Jennifer Lowe ,&nbsp;Zoe Vallotton ,&nbsp;Minolfa C. Prieto ,&nbsp;Lucienne S. Lara","doi":"10.1016/j.yexmp.2025.104977","DOIUrl":"10.1016/j.yexmp.2025.104977","url":null,"abstract":"<div><div>Salt-inducible kinase (SIK) is a serine/threonine kinase that acts as an intracellular Na<sup>+</sup> sensor, playing a role in salt-sensitive hypertension. We aimed to evaluate the therapeutic potential of YKL-05-099, a selective SIK inhibitor, in protecting kidney function and attenuating salt-sensitive hypertension. Male adult C57BL/6 J mice were randomly assigned to either a normal sodium (0.5 % NaCl; NS) or high‑sodium diet (4 % NaCl; HS) and further divided into two subgroups – receiving either intraperitoneal injection of saline or SIK inhibitor (SIKi; YKL-05-099, 20 mg/Kg/day). Blood pressure was measured by radiotelemetry for 15 days. On days 7 and 14, mice were placed in metabolic cages for 24 h urine collection. At the end of the treatment, blood and kidneys were collected for renal function assessment, and the renal cortex was extracted for biochemical analysis. HS intake led to a salt-sensitive hypertension model, as seen by increased systolic blood pressure (SPB), kidney damage and impairment in renal function. In the HS, SIKi treatment blocked the elevated SIK activity in the renal cortex, preventing kidney damage, proteinuria, and increased SBP. The Na<sup>+</sup> balance was positive due, partly, to a higher (Na<sup>+</sup>+K<sup>+</sup>)-ATPase activity in the HS. SIKi treatment exerted an anti-inflammatory effect by attenuating HS-dependent macrophage infiltration and ROS production and decreasing the metalloprotease activity. Consequently, the kidney damage biomarker monocyte chemotactic protein type 1 excretion was enhanced. In conclusion, SIK inhibition rescued HS mice from salt-sensitive hypertension and kidney insufficiency by blocking inflammation, metalloprotease activity, and oxidative stress.</div></div><div><h3>Significance</h3><div>Salt-sensitive hypertension is a major contributor to chronic kidney disease and cardiovascular morbidity worldwide. Despite its prevalence, the underlying mechanisms linking high salt intake to renal injury remain incompletely understood, and targeted therapies are lacking. This study identifies salt-inducible kinase (SIK) as a key mediator of salt-induced renal dysfunction and systemic hypertension. By using a selective SIK inhibitor (YKL-05-099), we demonstrate that pharmacological inhibition of SIK effectively prevents kidney damage, inflammation, oxidative stress, and high blood pressure in a preclinical model of salt-sensitive hypertension. These findings highlight SIK as a promising therapeutic target for preserving renal function and managing salt-induced hypertension, paving the way for novel interventions in salt-related cardiovascular and renal diseases.</div></div>","PeriodicalId":12176,"journal":{"name":"Experimental and molecular pathology","volume":"143 ","pages":"Article 104977"},"PeriodicalIF":2.8,"publicationDate":"2025-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144656118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Small intestinal bacteria accelerate aspirin-induced small intestinal injuries 小肠细菌加速阿司匹林引起的小肠损伤
IF 2.8 4区 医学 Q2 PATHOLOGY Pub Date : 2025-07-14 DOI: 10.1016/j.yexmp.2025.104984
Fumio Kakizaki , Teruo Miyazaki , Hajime Ueda , Junichi Iwamoto , Akira Honda , Tadashi Ikegami

Background

Small intestinal mucosal injuries are observed during treatment with enteric-coated, low-dose aspirin (LDA) through uncertain mechanism(s). Because aspirin (acetylsalicylic acid, ASA) is an acetylated form of the highly cytotoxic salicylic acid (SA), we hypothesized that SA deacetylated by esterases in the small intestine directly causes mucosal injuries. This study explored the mechanism(s) of ASA deacetylation to SA in the small intestinal environment.

Methods

ASA was added to the x, and deacetylation of added ASA and cell damage were evaluated. To explore the ASA deacetylation mechanism(s) in the intestinal environment, ASA was incubated with different pH phosphate buffers (4.01–9.10), pancreatic enzymes, homogenates of pancreas and IEC-6 cell, and caecum bacterial suspension (CBS). ASA and CBS were co-injected into the murine duodenum, and small intestinal damage was evaluated after an hour by histological observation.

Results

Intestinal cell damage was caused dependently on the deacetylation rate of added ASA to SA in the cell and culture media. In vitro, almost ASA was not deacetylated by incubation with different pH buffer, pancreatic enzymes, or IEC-6 cell homogenate, but deacetylation of ASA was significantly promoted with CBS. ASA deacetylation by bacterial esterases(s) was confirmed by adding an esterase-specific inhibitor, potassium fluoride. Furthermore, severe injuries throughout the entire murine small intestine were found after co-injection of ASA and CBS, but not after ASA alone.

Conclusions

Enteric-coated, LDA-induced mucosal injuries in the small intestine are mainly caused by direct cytotoxicity of SA deacetylated by enterobacterial esterase in the small intestine.
背景:在肠包被低剂量阿司匹林(LDA)治疗过程中观察到小肠黏膜损伤,但机制不确定。由于阿司匹林(乙酰水杨酸,ASA)是高细胞毒性水杨酸(SA)的乙酰化形式,我们假设SA在小肠内被酯酶去乙酰化直接导致粘膜损伤。本研究探讨了ASA在小肠环境下脱乙酰化为SA的机制。方法在x细胞中加入ASA,观察其去乙酰化程度及细胞损伤情况。为了探讨ASA在肠道环境中的去乙酰化机制,我们将ASA与不同pH的磷酸盐缓冲液(4.01-9.10)、胰腺酶、胰腺和IEC-6细胞匀浆以及盲肠细菌悬浮液(CBS)孵育。ASA和CBS联合注入小鼠十二指肠,1h后通过组织学观察小肠损伤情况。结果细胞和培养基中添加的ASA对SA的去乙酰化速率对肠细胞的损伤有依赖性。在体外,不同pH缓冲液、胰酶或IEC-6细胞匀浆孵育后,ASA几乎没有去乙酰化,但CBS显著促进了ASA的去乙酰化。通过添加酯酶特异性抑制剂氟化钾证实了细菌酯酶对ASA的去乙酰化作用。此外,ASA和CBS联合注射后,整个小鼠小肠均出现严重损伤,而ASA单独注射后未见损伤。结论senterc包被lda诱导的小肠粘膜损伤主要是由小肠内肠杆菌酯酶脱乙酰化SA直接细胞毒性引起的。
{"title":"Small intestinal bacteria accelerate aspirin-induced small intestinal injuries","authors":"Fumio Kakizaki ,&nbsp;Teruo Miyazaki ,&nbsp;Hajime Ueda ,&nbsp;Junichi Iwamoto ,&nbsp;Akira Honda ,&nbsp;Tadashi Ikegami","doi":"10.1016/j.yexmp.2025.104984","DOIUrl":"10.1016/j.yexmp.2025.104984","url":null,"abstract":"<div><h3>Background</h3><div>Small intestinal mucosal injuries are observed during treatment with enteric-coated, low-dose aspirin (LDA) through uncertain mechanism(s). Because aspirin (acetylsalicylic acid, ASA) is an acetylated form of the highly cytotoxic salicylic acid (SA), we hypothesized that SA deacetylated by esterases in the small intestine directly causes mucosal injuries. This study explored the mechanism(s) of ASA deacetylation to SA in the small intestinal environment.</div></div><div><h3>Methods</h3><div>ASA was added to the x, and deacetylation of added ASA and cell damage were evaluated. To explore the ASA deacetylation mechanism(s) in the intestinal environment, ASA was incubated with different pH phosphate buffers (4.01–9.10), pancreatic enzymes, homogenates of pancreas and IEC-6 cell, and caecum bacterial suspension (CBS). ASA and CBS were co-injected into the murine duodenum, and small intestinal damage was evaluated after an hour by histological observation.</div></div><div><h3>Results</h3><div>Intestinal cell damage was caused dependently on the deacetylation rate of added ASA to SA in the cell and culture media. In vitro, almost ASA was not deacetylated by incubation with different pH buffer, pancreatic enzymes, or IEC-6 cell homogenate, but deacetylation of ASA was significantly promoted with CBS. ASA deacetylation by bacterial esterases(s) was confirmed by adding an esterase-specific inhibitor, potassium fluoride. Furthermore, severe injuries throughout the entire murine small intestine were found after co-injection of ASA and CBS, but not after ASA alone.</div></div><div><h3>Conclusions</h3><div>Enteric-coated, LDA-induced mucosal injuries in the small intestine are mainly caused by direct cytotoxicity of SA deacetylated by enterobacterial esterase in the small intestine.</div></div>","PeriodicalId":12176,"journal":{"name":"Experimental and molecular pathology","volume":"143 ","pages":"Article 104984"},"PeriodicalIF":2.8,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144614742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Experimental and molecular pathology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1